Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 9, 2026.
Science Translational Medicine is a company within the Academic Publishing category. Science Translational Medicine is a premier scientific journal focused on translational medicine, published by the American Association for the Advancement of Science (AAAS). It serves as a platform for authors, reviewers, and advisors in the scientific community to submit, review, and manage manuscripts.
Science Translational Medicine is headquartered in Washington D.C. (AAAS Headquarters).
Science Translational Medicine is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Science Translational Medicine is Strong.
AI models classify Science Translational Medicine as a Incumbent. AI names brand first.
Science Translational Medicine appeared in 3 of 3 sampled buyer-intent queries (100%). The brand appears highly discoverable for direct searches related to its name and core function of scientific publishing in translational medicine, especially given its association with the 'Science' brand and AAAS.
Science Translational Medicine is perceived as a highly reputable and integral part of the Science family of journals, dedicated to advancing translational medicine through rigorous peer-reviewed publication. It facilitates the scientific communication process via a robust manuscript management system for authors, reviewers, and advisors, backed by the prestigious American Association for the Advancement of Science (AAAS). Key gap: None identified. The information is consistent and directly articulates the journal's purpose and its relationship to AAAS and the Science family of journals.
Of 4 key facts verified about Science Translational Medicine, 4 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
No specific vulnerabilities are apparent from the provided text, which focuses on the operational aspect of manuscript management for the journal. Potential vulnerabilities inherent to scientific publishing (e.g., managing retractions, plagiarism, or research integrity) are not addressed in this context but are standard industry challenges.
Buyers turn to Science Translational Medicine for Traditional mail/email submissions: Relying on physical mail or unstructured email for manuscript submissions, reviews, and communications, leading to significant delays and organizational challenges., Specialized publishing services: Engaging third-party agencies or university presses to manage the entire publication process, potentially incurring higher costs and less direct control over the journ, Not publishing research: Foregoing formal peer-reviewed publication of research, which would severely limit dissemination, credibility, and impact within the scientific community., among 3 documented problem areas.
Buyers evaluating Science Translational Medicine typically ask AI models about "Science Translational Medicine journal", "submit manuscript Science Translational Medicine", "AAAS translational medicine journal", and 1 similar queries.
Science Translational Medicine's core products are Scientific journal (publications), manuscript submission and peer review platform..
Science Translational Medicine uses Likely subscription-based access for readers, potentially author publication fees for open access (not specified in context). The manuscript management system itself is for contributors..
Science Translational Medicine serves Scientists, researchers, academics, medical professionals, authors, reviewers, and institutions involved in translational medicine..
Science Translational Medicine Its affiliation with the highly prestigious 'Science' family of journals, backed by the American Association for the Advancement of Science (AAAS), and its specific focus on translational medicine.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Incumbent
Official website: https://cts.sciencemag.org/
Last analyzed: August 9, 2026
Headquarters: Washington D.C. (source: official website)
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile